Prostate Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
Research To Practice | Oncology Videos
00:00
Niraparib in Hormone-Sensitive Disease (Amplitude)
Emmanuel summarizes Amplitude results showing RPFS benefit in HRR-mutated HSPC, strongest in BRCA1/2, no current FDA HSPC approval.
Play episode from 29:48
Transcript
